Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma

Details for Australian Patent Application No. 2002325088 (hide)

International Classifications

Event Publications

16 January 2003 Complete Application Filed

Priority application(s): 60/322,288 14.09.01 US

5 June 2003 Application Open to Public Inspection

Published as AU-B-2002325088

14 April 2005 Assignment before Grant

MediMolecular Pty Ltd The application has been assigned to Enterix Pty. Limited

9 August 2007 Application Accepted

Published as AU-B-2002325088

11 October 2007 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 19 Sep 2007. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2003

13 December 2007 Standard Patent Sealed

21 August 2008 Assignment Registered

Enterix Pty. Limited The patent has been assigned to Clinical Genomics Pty. Ltd.

25 September 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 19 Sep 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.